Peptide-based supramolecular vaccine systems

Currently approved replication-competent and inactivated vaccines are limited by excessive reactogenic-ity and poor safety profiles, while subunit vaccines are often insufficiently immunogenic without co-administering exogenous adjuvants. Self-assembling peptide-, peptidomimetic-, and protein-based bio-materials offer a means to overcome these challenges through their inherent modularity, multivalency, and biocompatibility. As these scaffolds are biologically derived and present antigenic arrays reminiscent of natural viruses, they are prone to immune recognition and are uniquely capable of functioning as self-adjuvanting vaccine delivery vehicles that improve humoral and cellular responses. Beyond this intrinsic immunological advantage, the wide range of available amino acids allows for facile de novo design or straightforward modifications to existing sequences. This has permitted the development of vaccines and immunotherapies tailored to specific disease models, as well as generalizable platforms that have been successfully applied to prevent or treat numerous infectious and non-infectious diseases. In this review, we briefly introduce the immune system, discuss the structural determinants of coiled coils, beta-sheets, peptide amphiphiles, and protein subunit nanoparticles, and highlight the utility of these materials using notable examples of their innate and adaptive immunomodulatory capacity. Statement of significance Subunit vaccines have recently gained considerable attention due to their favorable safety profiles rela-tive to traditional whole-cell vaccines; however, their reduced efficacy requires co-administration of re-actogenic adjuvants to boost immune responses. This has led to collaborative effort s between engineers and immunologists to develop nanomaterial-based vaccination platforms that can elicit protection with-out deleterious side effects. Self-assembling peptidic biomaterials are a particularly attractive approach to this problem, as their structure and function can be controlled through primary sequence design and their capacity for multivalent presentation of antigens grants them intrinsic self-adjuvanticity. This review introduces the various architectures adopted by self-assembling peptides and discusses their application as modulators of innate and adaptive immunity. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of Acta Materialia Inc.

Automated summary

Self-assembling peptide, peptidomimetic, and protein-based biomaterials offer a solution to the limitations of current vaccines, providing modularity, multivalency, and biocompatibility to enhance humoral and cellular responses. Their design flexibility allows for tailored vaccines and immunotherapies for specific disease models, while also serving as a generalizable platform for preventing or treating various infectious and non-infectious diseases.